Hang Lung Group's (HKG:10) Soft Earnings Don't Show The Whole Picture
Hang Lung Group's (HKG:10) Soft Earnings Don't Show The Whole Picture
The market for Hang Lung Group Limited's (HKG:10) shares didn't move much after it posted weak earnings recently. Our analysis suggests that while the profits are soft, the foundations of the business are strong.
恒隆集團有限公司(HKG: 10)在最近公佈疲軟的收益後,其股票市場沒有太大波動。我們的分析表明,儘管利潤疲軟,但業務基礎卻很牢固。
The Impact Of Unusual Items On Profit
不尋常物品對利潤的影響
Importantly, our data indicates that Hang Lung Group's profit was reduced by HK$993m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Hang Lung Group to produce a higher profit next year, all else being equal.
重要的是,我們的數據顯示,恒隆集團的利潤比去年減少了9.93億港元,這是由於不尋常的項目。看到不尋常的項目使公司利潤付出代價從來都不是一件好事,但從好的方面來看,情況可能遲早會好轉。我們調查了數千家上市公司,發現不尋常的物品本質上往往是一次性的。而且,畢竟,這正是會計術語的含義。假設這些不尋常的支出不會再次出現,因此,我們預計恒隆集團在其他條件相同的情況下,明年將實現更高的利潤。
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Hang Lung Group.
注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對恒隆集團的資產負債表分析。
Our Take On Hang Lung Group's Profit Performance
我們對恒隆集團盈利表現的看法
Unusual items (expenses) detracted from Hang Lung Group's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Hang Lung Group's statutory profit actually understates its earnings potential! And the EPS is up 29% annually, over the last three years. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. So while earnings quality is important, it's equally important to consider the risks facing Hang Lung Group at this point in time. Be aware that Hang Lung Group is showing 2 warning signs in our investment analysis and 1 of those can't be ignored...
去年,不尋常的項目(支出)減少了恒隆集團的收益,但明年我們可能會看到改善。基於這一觀察,我們認爲恒隆集團的法定利潤可能實際上低估了其盈利潛力!在過去三年中,每股收益每年增長29%。本文的目標是評估我們在多大程度上可以依靠法定收益來反映公司的潛力,但還有很多需要考慮的地方。因此,儘管盈利質量很重要,但考慮恒隆集團目前面臨的風險同樣重要。請注意,恒隆集團在我們的投資分析中顯示了兩個警告信號,其中一個不容忽視...
This note has only looked at a single factor that sheds light on the nature of Hang Lung Group's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
本報告僅研究了揭示恒隆集團利潤性質的單一因素。但是,還有很多其他方法可以讓你對公司的看法。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 「關注資金」,尋找內部人士正在買入的股票。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份擁有大量內幕持股的股票清單很有用。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。